Menu Back toFaculty

Safety Risk Communication for Medical Products

Learn how to enhance the effectiveness of safety risk communication in light of evolving regulatory expectations by attending this course.


  • Meredith  Smith, DrPH, PhD, MPA

    Meredith Smith, DrPH, PhD, MPA

    • Director, Risk Management, Global Drug Safety, Research and Development
    • Alexion Pharmaceuticals, Inc. , United States

    Meredith Smith is Risk Management Director at Alexion, Inc. where she leads a team responsible for medicinal product benefit-risk management. She is a behavioral scientist and health services researcher by training with over 15 years of experience in the pharmaceutical industry. She has served on numerous FDA expert panels, on CIOMS Working Groups VIII, IX and XI, and IMI-PREFER. Currently, she is the Pharmacovigilance Track Chair for the 2019 DIA Annual Meeting Planning Committee. Recently, she led the effort to develop the RIMES Statement, a set of quality reporting guidelines for risk minimization evaluation studies.

Contact us

Registration Questions?

Send Email

Agenda and Event Logistics

Send Email